Basilea Pharmaceutica AG
BPMUF
$77.40
$11.9018.17%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 80.48% | 98.98% | -52.75% | -53.53% | -16.46% |
| Total Depreciation and Amortization | 5.11% | 15.88% | 11.53% | 9.71% | 45.95% |
| Total Amortization of Deferred Charges | -45.90% | -40.37% | 3.24% | 1.46% | -14.66% |
| Total Other Non-Cash Items | 4.91% | 15.66% | 170.82% | 169.66% | 170.47% |
| Change in Net Operating Assets | -2,675.43% | -2,959.64% | 7,711.57% | 7,588.86% | -111.05% |
| Cash from Operations | -16.02% | -7.41% | -23.98% | -25.22% | 41.04% |
| Capital Expenditure | -30.01% | -43.36% | -103.31% | -100.00% | 24.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.46% | 56.48% | -465.45% | -454.17% | -92.49% |
| Cash from Investing | -9.72% | -20.93% | -111.56% | -108.09% | -273.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -24.06% | -24.06% | 25.85% | 25.85% | -78.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.88% | 64.88% | -4,124.85% | -4,124.85% | -10,219.59% |
| Cash from Financing | 65.62% | 62.09% | -34,722.40% | -34,129.92% | -20.70% |
| Foreign Exchange rate Adjustments | -1.49% | -13.11% | 72.02% | 72.43% | -111.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.59% | 88.08% | -40.91% | -41.87% | 73.78% |